Leukogene - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeLeukogene
Leukogene logo

Leukogene

0 followers

About Leukogene

Leukogene Therapeutics is a United States‑based biotechnology company developing MHC class II‑targeted cancer immunotherapies (M2T™ platform). By programming immune cells to recognize tumor‑associated antigens, the company aims to treat difficult‑to‑treat cancers and improve patient survival.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

Charleston, United States

Founded

2019

Employees

1 - 10

Status

Private

Website

https://leukogene.com